Product Program year 2023 Source: CMS Open Payments

VNS Therapy Sentiva Model 1000 Generator

Device Cardiology/Vascular Diseases

PDI 05425025750405

Open in the dashboard

General payments

$31,603,984

9,587 payments

Research payments

$0

0 payments

Through program year 2023, $31,603,984 in general payments and $0 in research payments were reported against VNS Therapy Sentiva Model 1000 Generator (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $16,773,290 4,697
2022 General $14,795,423 4,889
2021 General $35,271 1

Breakdown

Who paid General payments · program years 2021–2023
  1. LivaNova USA, Inc. $31,603,984 9,587 payments
Top recipients General payments · program year 2023
  1. Ivan Osorio Neurology · Kansas City, KS $16,065,516 96% · 4 payments
  2. Ahmed Abdelmoity Neurology with Special Qualifications in Child Neurology · Kansas City, MO $76,027 <1% · 86 payments
  3. Danielle Becker Epilepsy · Columbus, OH $65,257 <1% · 65 payments
  4. Kathryn Polovitz Internal Medicine · Parker, CO $59,930 <1% · 51 payments
  5. Angus Wilfong Neurology with Special Qualifications in Child Neurology · Phoenix, AZ $55,813 <1% · 41 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Neurology Psychiatry & Neurology $16,204,924 97% · 746 practitioners
  2. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $202,106 1% · 203 practitioners
  3. Epilepsy Psychiatry & Neurology $93,838 <1% · 46 practitioners
  4. Internal Medicine $60,430 <1% · 12 practitioners
  5. Clinical Neurophysiology Psychiatry & Neurology $42,323 <1% · 35 practitioners

The top 5 of 77 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Kansas $16,077,127 96% · 13 recipients
  2. Arizona $96,893 <1% · 32 recipients
  3. Pennsylvania $83,704 <1% · 93 recipients
  4. Missouri $77,879 <1% · 29 recipients
  5. Colorado $73,013 <1% · 31 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

9,587 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record